Who
Fady Ibraham Malik
EVP Research & Development
Company insider
Files Form 4 as: EVP Research & Development, Cytokinetics; Director, Rocket Pharmaceuticals.
In numbers
- Trades disclosed
- 443
- Buys
- 0
- Sells
- 124
- Bought
- $0
- Sold
- $37.3M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 4 Sep 2012
- Last trade
- 20 Oct 2026
- Last filed
- 20 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Oct 2026filed 20 Oct 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code M | $27K3,500 at $7.80 | filing |
| 20 Oct 2026filed 20 Oct 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $224K3,500 at $64.01 | filing |
| 20 Oct 2026filed 20 Oct 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 6 Oct 2026filed 6 Oct 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code M | $27K3,500 at $7.80 | filing |
| 6 Oct 2026filed 6 Oct 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $215K3,500 at $61.38 | filing |
| 6 Oct 2026filed 6 Oct 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 22 Sep 2026filed 22 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code M | $27K3,500 at $7.80 | filing |
| 22 Sep 2026filed 22 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $239K3,500 at $68.29 | filing |
| 22 Sep 2026filed 22 Sep 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 22 Sep 2026filed 22 Sep 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 22 Sep 2026filed 22 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code M | $27K3,500 at $7.80 | filing |
| 22 Sep 2026filed 22 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $239K3,500 at $68.29 | filing |
| 8 Sep 2026filed 8 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code M | $27K3,500 at $7.80 | filing |
| 8 Sep 2026filed 8 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $264K3,500 at $75.46 | filing |
| 8 Sep 2026filed 8 Sep 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 8 Sep 2026filed 8 Sep 2026 | CYTK Cytokineticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 8 Sep 2026filed 8 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code M | $27K3,500 at $7.80 | filing |
| 8 Sep 2026filed 8 Sep 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $264K3,500 at $75.46 | filing |
| 18 Aug 2026filed 18 Aug 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Code M | $27K3,500 at $7.80 | filing |
| 18 Aug 2026filed 18 Aug 2026 | CYTK CytokineticsBiotechnology | SEC FORM 4 Sold | $265K3,500 at $75.82 | filing |
News
Analyzing Inhibrx Biosciences (NASDAQ:INBX) and Cytokinetics (NASDAQ:CYTK)CYTK · themarketsdaily.com · 25 Oct 2026Head to Head Survey: Maze Therapeutics (NASDAQ:MAZE) vs. Cytokinetics (NASDAQ:CYTK)CYTK · dailypolitical.com · 18 Oct 2026Contrasting Gain Therapeutics (NASDAQ:GANX) and Cytokinetics (NASDAQ:CYTK)CYTK · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Fady Ibraham Malik; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.